Bhuvaneish T.S joined the Scottish Centre for Regenerative Medicine – University of Edinburgh, almost two years ago to establish and drive the use of CRISPR Cas9 within the University’s lab and apply it as a model for different disorders. Pharma IQ spoke to Bhuvaneish, a Post Doctorate Fellow in neurodegenerative disorders, to discover more about his ongoing CRISPR Cas9 project.